Dr. ERIC FEIGL DING is an epidemiologist, nutritionist, and faculty at Harvard School of Public Health. He is also Director of Epidemiology with Microclinic International, business school faculty at Management Center Innsbruck, and a Soros Fellow.
His work focuses on the intersection of epidemiology, global health and interventions for disease prevention, virality of social networks, social networks on health behaviors, and social media technology for health. He has published in leading journals, including the New England Journal of Medicine, Journal of the American Medical Association, The Lancet, and Health Policy. His 90+ publications have received over 8000 external citations (H-Index 35). He is Principal Investigator of several randomized controlled trials of social network interventions against obesity and diabetes in the U.S. and abroad. Altogether, his competitively awarded projects have been financed with over $10 million in funding.
A Google Tech Talk keynote speaker, a World Economic Forum Global Shaper, he has also served as: consultant for the World Health Organization, adviser to the European Commission (EC), moderator and committee chair of the EC summit Diabesity, advisor to the Slovenian Ministry of Health, judge for the annual VH1 Do Something Awards, interviewer for the Soros Fellowship, and member of the Global Burden of Disease Project and US Disease Burden Collaboration.
A cancer prevention advocate and childhood tumor survivor, he founded the online Campaign for Cancer Prevention, on Causes. In total online reach, he directed several health and disease prevention advocacy platforms, with 17 million members. Recognized at Google, he also led a 130-year study of Major League Baseball players and risk of mortality across half-million player-years of data. In 2006, he was noted for his key role in leading a two-year-long investigation into the controversial drug safety and risks of Vioxx®, Celebrex®, and Bextra® that drew FDA and national attention. Highlighted and express-published in JAMA, as chief corresponding author, he was recognized in the New York Times.
He is also the inventor of several scientific innovations in epidemiology and nutrition: the Lipophilic Index and Lipophilic Load for fatty acids, the spaghetti meta-regression plot, the social network propagation intraclass ratio, the Evidenced Formal Coverage Index for universal healthcare coverage, and isotemporal substitution risk models for time displacement.
He was awarded the 2014 Global Health Project of the Year by the Consortium of Universities for Global Health, awarded the 2012 Outstanding Young Leader Award from the Boston Chamber of Commerce, awarded the 2015 American Heart Association Scott Grundy Award, and named among Craig Newmark’s “16 People and Organizations Changing the World in 2012”. His work was cited by the directors of CDC and CMMS in the framework of the “Million Hearts” initiative, and his research recognized twice as ‘Best of the American Heart Association’. He has been featured in the Chronicle of Philanthropy, Newsweek, The New York Times, and profiled in several books: CauseWired (2008), Zilch (2010), Shift & Reset (2011), and Thinfluence (2014). He was awarded the Paul and Daisy Soros Fellowship in 2008.
He attended The Johns Hopkins University, graduating with Honors in Public Health and Phi Beta Kappa (junior year) at age 21. He completed his dual doctorate in epidemiology and doctorate in nutrition at age 23 from Harvard University. He also completed his post-doctoral fellowship at the Harvard School of Public Health. At Harvard, he has taught more than a dozen graduate and undergraduate courses in global health, for which he received the Derek Bok Distinction in Teaching Award from Harvard College.